Biblio
Export 198 results:
Author Title Type [ Year] Filters: First Letter Of Title is I [Clear All Filters]
“In Vitro Potency and Preclinical Pharmacokinetic Comparison of All-D-Enantiomeric Peptides Developed for the Treatment of Alzheimer's Disease.”, J Alzheimers Dis, vol. 64, no. 3, pp. 859-873, 2018.
, “In vivo Depiction of α7 Nicotinic Receptor Loss for Cognitive Decline in Alzheimer's Disease.”, J Alzheimers Dis, vol. 61, no. 4, pp. 1355-1365, 2018.
, “In Vivo MRI of Amyloid Plaques in a Cholesterol-Fed Rabbit Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 64, no. 3, pp. 911-923, 2018.
, “In Vivo Visualization of Tau Accumulation, Microglial Activation, and Brain Atrophy in a Mouse Model of Tauopathy rTg4510.”, J Alzheimers Dis, vol. 61, no. 3, pp. 1037-1052, 2018.
, “Incidence and Prevalence of Antiepileptic Medication Use in Community-Dwelling Persons with and without Alzheimer's Disease.”, J Alzheimers Dis, vol. 66, no. 1, pp. 387-395, 2018.
, “Increased Albumin Oxidation in Cerebrospinal Fluid and Plasma from Alzheimer's Disease Patients.”, J Alzheimers Dis, vol. 63, no. 4, pp. 1395-1404, 2018.
, “Increased Foxo3a Nuclear Translocation and Activity is an Early Neuronal Response to βγ-Secretase-Mediated Processing of the Amyloid-β Protein Precursor: Utility of an AβPP-GAL4 Reporter Assay.”, J Alzheimers Dis, vol. 61, no. 2, pp. 673-688, 2018.
, “Increased Insoluble Amyloid-β Induces Negligible Cognitive Deficits in Old AppNL/NL Knock-In Mice.”, J Alzheimers Dis, vol. 66, no. 2, pp. 801-809, 2018.
, “Increased Prevalence of Obesity/Type 2 Diabetes and Lower Levels of Lithium in Rural Texas Counties May Explain Greater Alzheimer's Disease Risk.”, J Alzheimers Dis, vol. 64, no. 1, pp. 303-308, 2018.
, “Increased Risk of Dementia in Subjective Cognitive Decline if CT Brain Changes are Present.”, J Alzheimers Dis, vol. 66, no. 2, pp. 483-495, 2018.
, “Increased Serum Acylated Ghrelin Levels in Patients with Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 61, no. 2, pp. 545-552, 2018.
, “Increased Vulnerability of the Hippocampus in Transgenic Mice Overexpressing APP and Triple Repeat Tau.”, J Alzheimers Dis, vol. 61, no. 3, pp. 1201-1219, 2018.
, “Increasing Diagnostic Accuracy of Mild Cognitive Impairment due to Alzheimer's Disease by User-Independent, Web-Based Whole-Brain Volumetry.”, J Alzheimers Dis, vol. 65, no. 4, pp. 1459-1467, 2018.
, “INDEL Length and Haplotypes in the β-Synuclein Gene: A Key to Differentiate Dementia with Lewy Bodies?”, J Alzheimers Dis, vol. 65, no. 1, pp. 207-219, 2018.
, “The Independent Associations of Physical Activity and Sleep with Cognitive Function in Older Adults.”, J Alzheimers Dis, vol. 63, no. 4, pp. 1469-1484, 2018.
, “An Inducible Alpha-Synuclein Expressing Neuronal Cell Line Model for Parkinson's Disease1.”, J Alzheimers Dis, vol. 66, no. 2, pp. 453-460, 2018.
, “Induction of Amyloid-β42 Production by Fipronil and Other Pyrazole Insecticides.”, J Alzheimers Dis, vol. 62, no. 4, pp. 1663-1681, 2018.
, “Inflammatory Cytokine, IL-1β, Regulates Glial Glutamate Transporter via microRNA-181a in vitro.”, J Alzheimers Dis, vol. 63, no. 3, pp. 965-975, 2018.
, “Influence of Butyrylcholinesterase in Progression of Mild Cognitive Impairment to Alzheimer's Disease.”, J Alzheimers Dis, vol. 61, no. 3, pp. 1097-1105, 2018.
, “Influence of Lewy Pathology on Alzheimer's Disease Phenotype: A Retrospective Clinico-Pathological Study.”, J Alzheimers Dis, vol. 63, no. 4, pp. 1317-1323, 2018.
, “The Influence of Polypharmacy on the Initiation of Anti-Dementia Therapy in Germany.”, J Alzheimers Dis, vol. 64, no. 3, pp. 827-833, 2018.
, “The Influence of the Val66Met Polymorphism of Brain-Derived Neurotrophic Factor on Neurological Function after Traumatic Brain Injury.”, J Alzheimers Dis, vol. 65, no. 4, pp. 1055-1064, 2018.
, “Inhibition of Histone Acetylation by ANP32A Induces Memory Deficits.”, J Alzheimers Dis, vol. 63, no. 4, pp. 1537-1546, 2018.
, “The In-Hospital Length of Stay after Hip Fracture in Octogenarians: Do Delirium and Dementia Shape a New Care Process?”, J Alzheimers Dis, vol. 66, no. 1, pp. 281-288, 2018.
, “Innovative Biomarkers for Alzheimer's Disease: Focus on the Hidden Disease Biomarkers.”, J Alzheimers Dis, vol. 62, no. 4, pp. 1507-1518, 2018.
,